# A Pilot Study to Evaluate the Safety and Immunogenicity of Low Dose Flu Vaccines

> **NCT00558649** · NA · COMPLETED · sponsor: **NanoPass Technologies Ltd** · enrollment: 180 (actual)

## Conditions studied

- Influenza, Human

## Interventions

- **BIOLOGICAL:** Flu Vaccine (FLUARIX®)

## Key facts

- **NCT ID:** NCT00558649
- **Lead sponsor:** NanoPass Technologies Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2007-09
- **Final completion:** 2007-12
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2013-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00558649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00558649, "A Pilot Study to Evaluate the Safety and Immunogenicity of Low Dose Flu Vaccines". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00558649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*